Journal_1_2014_final_WEB

More documents

Recommendations

Info

Leading the way SETTING THE STANDARD FOR INNOVATION & EVIDENCE PRO EN PREVENTION Can you afford the impact of not using our proven prevention? ✔ The only dressing supported by results of randomised controlled trials 1,2 ✔ Significant reduction in pressure ulcer incidence 3,4,5,* ✔ Substantial cost savings 4,6,* ✔ Combats 4 extrinsic causes of pressure ulcers 7,8,9,* Find out more www.molnlycke.com/puprevention References: 1. Kalowes P. et al. Use of a soft silicone, self-adherent, bordered foam dressing to reduce pressure ulcer formation in high risk patients: a randomized clinical trial. Poster presentation at Symposium on Advanced Wound Care Fall, Baltimore, Maryland, United States of America. 2012. 2. Santamaria N. et al. A randomised controlled trial of the effectiveness of soft silicone multi-layered foam dressings in the prevention of sacral and heel pressure ulcers in trauma and critically ill patients: the border trial. International Wound Journal 2013; doi: 10.1111/iwj.12101. 3. Brindle C.T. and Wegelin J.A. Prophylactic dressing application to reduce pressure ulcer formation in cardiac surgery patients. Journal of Wound Ostomy & Continence Nursing. 2012; 39(2):133-142. 4. Cherry C. and Midyette P. The Pressure Ulcer Prevention Care Bundle: a collaborative approach to preventing hospital-acquired pressure ulcers. Poster presentation at Magnet Research Day, Alabama, United States of America. 2010. 5. Chaiken N. Reduction of sacral pressure ulcers in the intensive care unit using a silicone border foam dressing. Journal of Wound Ostomy & Continence Nursing 2012;39(2):143-145. 6. Padula W. et al. Improving the Quality of Pressure Ulcer Care With Prevention, A Cost-Effectiveness Analysis. Medical Care. 2011; 49(4). 7. Call, E. Pederson, J., Bill, B.Craig Oberg PhD, Martin Ferguson- Pell PhD, Wounds -2013, 25(4):94-103. 8. Call, E. Pederson, J., Bill, B. In vitro comparison of the prophylactic properties of two leading commercially available wound dressings. Poster presentation at Symposium on Advanced Wound Care Fall, Baltimore, Maryland, United States of America. 2012. 9. Call, E. Black J., Clark M. ,Alves P., Brindle T., Dealey C. Santa Maria, N International Panel Studies Creation of Guidance on Dressing Use in Prevention of Pressure Ulcers poster presentation SAWC spring 2012. *In addition to current prevention protocols.
Scientific Communication Results from the world’s largest telemedicine project – the Whole System Demonstrator Summary Telemedicine is highlighted as a solution to future healthcare challenges, but currently extant research is criticized for not being sufficient and of poor quality The Whole System Demonstrator (WSD) is the largest and most comprehensive research project performed to date, that evaluated telemedicine effectiveness and costs in patients with chronic diseases including lung disease, heart disease, and diabetes. The trial was initiated in 2008 as a cluster randomized study including 3,230 patients from 179 general practices from three regions in the UK. The objective of the present review is to summarize the results from the WSD based on study data published to date. Results from five publications show that telehealth reduces mortality (odds ratio 0.54), the number of hospital admissions during a 12-month observation period, and patient use of secondary care. However, it is not yet clearly established which specific patient groups will realize these benefits, nor is it known what the underlying mechanisms of these advantageous effects are. The savings achieved by reducing hospital costs are, at least for now, less than the extra costs incurred by using telehealth, which increased overall net healthcare costs by 15%. There remains a strong need to expand focused research into telemedicine technology and applications to enhance the well-being, health outcomes, and quality-of-life of individuals in our rapidly ageing population. INTRODUCTION Telemedicine is applied to a number of patient groups on a global level and, among other applications, is used in diagnosing and treating wounds 1 . Politicians and policy makers generally welcome telemedicine as one solution to the challenges imposed by the changing demographics in the western world. However, evidence regarding the clinical outcomes is scarce and more knowledge on patient perception and the organizational and economic consequences of telemedicine is needed. One systematic review showed that clinical outcomes have been included in less than 5% of over 1,300 trials studying telemedicine 2 . Another review also states that there is a severe lack of randomized controlled studies that have focused on telemedicine 3 . Further, it has been demonstrated that studies on telemedicine use in general do not follow recognized standards for reporting scientific results 4 . A Danish review comprising individuals suffering from chronic lung disease that are treated via telemedicine underlines the need for larger studies of higher quality 5 . Another recent review of 141 randomized studies using tele medicine across several specialties (i.e., asthma, chronic lung disease, heart Kristian Kidholm 1 Birthe Dinesen 2 Anne-Kirstine Dyrvig 3 Benjamin Schnack Rasmussen 4 Knud B. Yderstraede 4 Conflict of interest: None declared. ICMJE formulars from the authors are available on request. The article was originally published in Danish. For the publication in EWMA, journal-specific references to wound care have been included. Orig. publ; Ugeskr Læger 2014;176: V05130299 1 Center for Innovative Medical Technology, Odense University Hospital, Odense, Denmark 2 Integrative Neuroscience Research Group, Centre for Senses and Motor interaction, Institute of Medical and Health Technology, Faculty of Health, Aalborg University, Aalborg, Denmark 3 Institute of Health Research, University of Southern Denmark, Odense, Denmark. 4 Department of Medical Endocrinology and University Centre for Wound Healing, Odense University Hospital and University of Southern Denmark, Odense, Denmark Correspondence: kristian.kidholm@rsyd.dk EWMA Journal 2014 vol 14 no 1 43
Page 1 and 2: Volume 14 Number 1 May 2014 Publish
Page 3 and 4: BeneHold TASA The future of wound
Page 5 and 6: 24th Conference of the European Wou
Page 8 and 9: The exciting new Negative Pressure
Page 10 and 11: hospital found a significant decrea
Page 12 and 13: Figure 3: Rate of PU at different l
Page 14 and 15: Science, Practice and Education Any
Page 16 and 17: Visit us at EWMA 2014 Enjoy the fre
Page 18 and 19: 30 25 20 15 Figure 2: Number of pat
Page 20 and 21: Figure 5. Ulcers on the forehead fo
Page 22 and 23: Science, Practice and Education tiv
Page 24 and 25: * At smith&nephew we fully support
Page 26 and 27: after revascularization of the coll
Page 28 and 29: 12th Scientific Meeting of the Diab
Page 30 and 31: Wound healing has always had villai
Page 32 and 33: During period of stress or trauma s
Page 34 and 35: Nutrition Intervention Ultimately,
Page 36 and 37: NO ONE IMAGINED WOUND THERAPY COULD
Page 38 and 39: Apart from the growth factors, acti
Page 40 and 41: Science, Practice and Education Fig
Page 44 and 45: Table 1. Survey on included studies
Page 46 and 47: 10.8% lower (statistically signific
Page 48: Scientific Communication heart dise
Page 51 and 52: Scientific Communication Nutrition
Page 53 and 54: Eating problems, Shopping and Cooki
Page 55 and 56: Scientific Communication As mention
Page 57 and 58: Scientific Communication strategies
Page 59 and 60: BIOFILM COURSES 2014 m MADRID, SPAI
Page 61 and 62: Innovation, know how and technolgy
Page 69 and 70: With Polymem, ® finger and toe inj
Page 71 and 72: Cochrane Reviews ABSTRACTS OF RECEN
Page 73 and 74: Cochrane Reviews or adhesive tape.T
Page 75 and 76: Cochrane Reviews studies were noted
Page 77 and 78: Cochrane Reviews infection status a
Page 79 and 80: EWMA English English Polish Lithuan
Page 81 and 82: EWMA MADRID A city where you will f
Page 83 and 84: Strong when wet 1,2 Gentle on the b
Page 85 and 86: Now available - DURAFIBER Ag with a
Page 87 and 88: EWMA n GNEAUPP 2014 Christina Lindh
Page 89 and 90: will be held at this year’s EWMA
Page 91 and 92: Submit your next paper to Phlebolog
Page 93 and 94:
Nordic Diabetic Foot Symposium 2014
Page 95 and 96:
Programme in Austria 25th Conferenc
Page 97 and 98:
JOURNAL CITATION REPORTS 2013 SPECI
Page 99 and 100:
EWMA Managing Wounds as a Team - Ex
Page 101 and 102:
Organisations Conference Calendar C
Page 104 and 105:
Organisations EB-CLINET - Clinical
Page 106 and 107:
Organisations The Korean Wound Mana
Page 108 and 109:
Organisations UPDATE WAWLC World Al
Page 110 and 111:
Cooperating Organisations AEEVH Spa
Page 112:
6 Editorial Science, Practice and E
show all

Journal_1_2014_final_WEB

Create successful ePaper yourself

Delete template?

Save as template?